Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2010
07/20/2010US7759081 Diagnosing cancer in humans; obtain sample, detect annexin protein in sample, amplified concentration of annexins indicates cancer
07/20/2010US7759080 Method of determining pregnancy toxemia
07/20/2010US7759079 Methods of diagnosing inflammatory bowel disease
07/20/2010US7759078 Diagnosis and treatment of cancer
07/20/2010US7759077 non-invasive method for facilitating diagnosis of bladder cancer; quantifying the amount of the sFas protein in a urine sample; automated detection of a cell proliferative disorder
07/20/2010US7759076 for predicting the prognosis of chronic lymphocytic leukemia (CLL); malignancy of bone marrow cells; increased reliability, sensitivity and greater quantitative precision
07/20/2010US7759075 Molecules for the treatment of lung disease involving an immune reaction to connective tissue found in the lung
07/20/2010US7759074 Analyzing an antigen or antibody in a sample by contacting sample with a protease-treated albumin , incubate with latex particles, monitor turbity and latex agglutination
07/20/2010US7759073 Electronic methods for the detection of analytes
07/20/2010US7759072 high reaction specificity and sensitivity; immunoassaying a target antigen utilizing reactivation of an apoenzyme; detecting a hydrogen peroxide produced by apo-D-amino acid oxidase
07/20/2010US7759071 Using nucleosome concentration after exposure to antitumor and/or anti-ischemic agents as diagnostic indicator of treatment efficacy
07/20/2010US7759070 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
07/20/2010US7759069 Compositions and methods for measuring nuclear receptor ligands
07/20/2010US7759068 Eukaryotic cells are treated with a polynucleotide which encodes a polypeptide which inhibits the expression or the function of proteins synthesized or secreted by tumors, and thus inhibits the increase in tissue volume or the metastasis of the tumors; for prostatic tissue
07/20/2010US7759067 Method for determining the amount of an analyte with a disc-shaped microfluidic device
07/20/2010US7759065 Digesting a target nucleic acid molecule; capturing digested fragments on a solid support that containing oligonucleotides complementary, detecting hybrids and molecular weight of captured fragments by mass spectrometry to identify mutations; Fast and highly accurate
07/20/2010US7758893 Enteral compositions for the prevention and/or treatment of sepsis
07/20/2010US7758863 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
07/20/2010US7758858 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders
07/20/2010US7758853 A protein obtainable from mouse liver, able to produce interferon- gamma by immunocompetent cells; producing antitumor agent
07/20/2010US7758852 OX40R binding agents
07/20/2010US7758815 1st specimen receiving chamber connected to a 2nd testing device chamber by a selective specimen transfer site, and a 3rd chamber having inlets for depositing another portion of the specimen from the 1st chamber into the third chamber; tamper-proof; used, e.g., to test urine for presence of drugs
07/20/2010US7758811 Multi channel, flow cytometry units; computer controlled fluid flow, laser analysis, sorting
07/20/2010US7758744 Dual glucose-turbidimetric analytical sensors
07/20/2010US7758734 Methods and apparatus for the measurement of hydrogen sulphide and thiols in fluids
07/20/2010US7758511 System for quantifying blood flow in tissue with periodic updating of tissue baseline conditions
07/20/2010US7758283 Geomorphology for environmental remediation process and systems
07/20/2010US7757635 Method and apparatus for detecting mastitis
07/20/2010US7757623 Explosion indicators for use in explosion-proof enclosures with critical equipment
07/20/2010CA2655875C Detection of antibiotics
07/20/2010CA2566040C Method for increasing the dynamic measuring range of test elements, especially immunological test elements, that are based on specific binding reactions
07/20/2010CA2468858C Breath test
07/20/2010CA2453252C Automated system and method for processing multiple liquid-based specimens
07/20/2010CA2445776C Differential photochemical & photomechanical processing
07/20/2010CA2424454C Cyanine dyes
07/20/2010CA2423784C Infrared thermographic screening technique for semiconductor-based chemical sensors
07/20/2010CA2421339C Novel polypeptides and nucleic acids encoding the same
07/20/2010CA2410322C Processing chamber
07/20/2010CA2400702C Method and system for characterization and mapping of tissue lesions
07/20/2010CA2396805C Method and apparatus for automatic tissue staining
07/20/2010CA2370519C Nucleic acids encoding a mutt domain-containing polypeptide
07/20/2010CA2362055C A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
07/20/2010CA2309679C Method of identifying binding site domains that retain the capacity of binding to an epitope
07/20/2010CA2289980C Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
07/20/2010CA2278786C Selection of proteins using rna-protein fusions
07/20/2010CA2271249C Macromolecular neuraminidase-binding compounds
07/20/2010CA2268740C High density immobilization of nucleic acids
07/20/2010CA2191063C Dna encoding glutamate gated chloride channels
07/15/2010WO2010081173A2 Modified antibody compositions, methods of making and using thereof
07/15/2010WO2010081158A2 Blood test for the detection of cancer
07/15/2010WO2010081116A2 System and method for analyzing properties of meat using multispectral imaging
07/15/2010WO2010081108A2 Small specimen staining and diagnosing of cells
07/15/2010WO2010081098A2 Gyratory compactor apparatuses and associated methods
07/15/2010WO2010081076A2 Imprinted polymer nanoparticles
07/15/2010WO2010080994A2 Process for regulating immune response
07/15/2010WO2010080978A2 Pre-depletion of leukocytes in whole blood samples prior to the capture of whole blood sample components
07/15/2010WO2010080962A2 Heat shock protein deficiencies as model systems for brain pathology and cancer
07/15/2010WO2010080933A1 Cancer biomarkers
07/15/2010WO2010080804A1 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
07/15/2010WO2010080765A2 High-throughput production of ingestible event markers
07/15/2010WO2010080710A2 Sample collection and measurement in a single container by back scattering interferometry
07/15/2010WO2010080708A2 Methods and systems for interferometric analysis
07/15/2010WO2010080640A2 A ph modulation method to detect ligand-receptor binding
07/15/2010WO2010080617A2 Detecting and sorting methylated dna using a synthetic nanopore
07/15/2010WO2010080518A1 Methods and materials for determining isoelectric point
07/15/2010WO2010080506A1 Compositions and methods to prevent cancer with cupredoxins
07/15/2010WO2010080424A1 Peptide linkers for effective multivalent peptide binding
07/15/2010WO2010080327A1 Photo-electro-chemical oxygen demand sensor, fluid sensor system, and method for determining one or more characteristics of a foreign material in a fluid
07/15/2010WO2010080130A1 Systems and methods for classifying and screening biological materials for use for therapeutic and/or research purposes
07/15/2010WO2010080007A2 Lipoproteins derived from gram-positive bacteria functioning as toll-like receptor 2 ligand
07/15/2010WO2010079994A2 Anti-cancer drug screening method using rorα
07/15/2010WO2010079919A2 Method for screening matrix metalloproteinase
07/15/2010WO2010079845A1 Blood coagulation system analyzer, and blood coagulation system analysis method and program
07/15/2010WO2010079833A1 Novel cancer antigen eef2
07/15/2010WO2010079815A1 Aldosterone calculating scale
07/15/2010WO2010079739A1 Method for assaying all types of influenza viruses
07/15/2010WO2010079625A1 Testing method for bolts
07/15/2010WO2010079491A1 Volatile organic compounds as diagnostic markers in the breath for lung cancer
07/15/2010WO2010079490A1 Volatile organic compounds as diagnostic markers in the breath for lung cancer
07/15/2010WO2010079479A2 A multiple testing apparatus and method
07/15/2010WO2010079456A2 A state sensor
07/15/2010WO2010079430A1 Modular dna-binding domains and methods of use
07/15/2010WO2010079428A2 Biomarkers for appetite regulation
07/15/2010WO2010079384A1 Apparatus for measuring bughole rating of concrete surface
07/15/2010WO2010079357A1 Rapid bioluminescence detection system
07/15/2010WO2010079339A2 Factors
07/15/2010WO2010079329A1 Method and apparatus for alcohol concentration detection in a blood sample
07/15/2010WO2010079253A2 Bio-markers for diagnosing fibrosis
07/15/2010WO2010079230A1 Method for the selection of endothelial cells death inducers via netrin-1 and its applications
07/15/2010WO2010079208A1 New receptor binding ligands, their use in the detection of cells with biological interest
07/15/2010WO2010079158A1 Methods for the treatment, the prognostic assessment and the detection of breast cancer
07/15/2010WO2010079076A2 Autosomal dominant polycystic kidney disease (adpkd)
07/15/2010WO2010078872A2 Enrichment and identification of fetal cells in maternal blood and ligands for such use
07/15/2010WO2010078868A1 Method and device for measuring the activity of enzymes after inhibitor removal
07/15/2010WO2010057985A3 Salmonella marker vaccine
07/15/2010WO2010053315A9 Method for analyzing the substrate specificity of serine/threonine kinase using a peptide library
07/15/2010WO2010052342A3 Chemical messenger sensor
07/15/2010WO2010049816A3 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof
07/15/2010WO2010049672A3 Methods and products for measuring free immunoglobulin light chain molecules
07/15/2010WO2010046530A8 Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes